Whooping cough vaccine loses strength over time

accreditation

A booster shot of the whooping cough vaccine that is given to preteens loses a large measure of effectiveness within a few years, new research reveals.

Recent surge

The U.S. Centres for Disease Control and Prevention investigation may help explain a recent surge in the number of Americans with whooping cough (pertussis).

"Among adolescents, within the first year following immunisation the vaccine effectiveness was 73 percent," said study author Dr. Anna Acosta, an epidemiologist in the CDC's division of bacterial diseases. "But by two to four years out, it had fallen to about 34 percent effectiveness."

Still, Acosta stressed, "We really need to keep in mind that while vaccines are not perfect, they are still the best way to provide protection among children and adolescents."

Read: Types of cough

In the United States, very young children get a five-dose series of the whooping cough vaccine. A sixth dose of the vaccine has been recommended for adolescents since 2005.

Characterised by severe coughing, whooping cough can impede breathing, cause vomiting and interfere with sleep, the CDC says. Infants face a notably high risk for severe disease and death from whooping cough, Acosta said. The risk of complications for teens and adults is lower but still significant.

Immunisations overall have reduced the rate of whooping cough cases by about 80 percent since the pre-vaccine era, Acosta said.

Vaccine modification

But vaccine modification may have also contributed to the recent uptick in cases, the researchers said. In 1997, the "accellular pertussis vaccine" for young children replaced the "whole-virus" DTaP vaccine used for the five-dose series.

In 2005, because of concerns about the vaccine's duration, a sixth dose – called Tdap – was added to the vaccine protocol, specifically for kids aged 11 and 12 and adults who never got Tdap. (The combination vaccine also protects against tetanus and diphtheria).

Even with high childhood and preteen vaccine coverage, the United States experienced about 48,000 cases of whooping cough in 2012 – the most since 1955, according to the CDC.

Read: What is a cough?

Scientists began wondering if waning immunity – a known issue for the old vaccine – also plagues the new series.

To answer that concern, the study team zeroed in on a pertussis epidemic in Washington State in 2012. Five thousand people came down with whooping cough, many of them in their early teens, despite the state's 86 percent Tdap coverage rate.

Focus was placed on about 1,700 teens born between 1993 and 2000 – kids who would have received the newer vaccine. This group experienced 450 cases of whooping cough.

Tdap effectiveness plummeted

Overall, Tdap effectiveness for this group was pegged at about 64 percent, but that plummeted to 34 percent two to four years post-inoculation, the investigators found.

Similar findings emerged from a Wisconsin study, leading the CDC to attribute the recent spike in whooping cough to a waning of Tdap effectiveness.

Going forward, CDC investigators said two things are needed: a better understanding of how exactly the pertussis bacteria works and an improved vaccine. But for the time being they don't recommend any shift in vaccine protocols.

Read: Treating a cough

Acosta stressed that expectant mothers should continue to get inoculated against whooping cough during their third trimester. Maternal inoculation "will protect the infant until they are able to receive their own doses at 2, 4, and 6 months of age," she said.

Another reason to get vaccinated, Acosta said, is that if an immunised person does become sick, the disease will be less severe.

Dr. Paul Offit, chief of infectious diseases at Children's Hospital of Philadelphia, expressed little surprise at the notion that Tdap effectiveness wanes with time.

However, "you're still better off getting the vaccine than not," he said.

"I think the path forward is to get a better vaccine," Offit added, "and people are working on that."

The study findings are published online in the journal Paediatrics.

Read More:

Conditions associated with a cough

Five of the weirdest things to cause a cough

Coughing up blood: when should you be concerned?

Image: Teddy bear with syringe from Shutterstock

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
The ANC's leadership race is heating up. Who do you think will be elected party president at Nasrec in December?
Please select an option Oops! Something went wrong, please try again later.
Results
Nkosazana Dlamini-Zuma has got it in the bag
7% - 809 votes
I foresee a second term for Cyril Ramaphosa
83% - 9259 votes
Don’t discount a Zweli Mkhize win
10% - 1086 votes
Vote
Rand - Dollar
18.01
-1.3%
Rand - Pound
20.11
+0.1%
Rand - Euro
17.64
-0.4%
Rand - Aus dollar
11.55
-0.0%
Rand - Yen
0.12
-1.0%
Gold
1,713.07
-0.2%
Silver
20.66
+0.1%
Palladium
2,253.50
-0.2%
Platinum
925.00
+0.3%
Brent Crude
93.37
+1.7%
Top 40
59,416
+0.4%
All Share
65,833
+0.3%
Resource 10
63,279
-0.6%
Industrial 25
80,027
+1.0%
Financial 15
13,997
+0.3%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE